Cargando…
Down-regulation of OPA1 in patients with primary open angle glaucoma
PURPOSE: Heterozygous optic atrophy type1 (OPA1) mutations are responsible for dominant optic atrophy, and the down regulation of OPA1 expression in patients with Leber hereditary optic neuropathy may imply that Opa1 protein levels in mitochondria play a role in other spontaneous optic neuropathies...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086630/ https://www.ncbi.nlm.nih.gov/pubmed/21552501 |
_version_ | 1782202710195437568 |
---|---|
author | Bosley, Thomas M. Hellani, Ali Spaeth, George L. Myers, Jonathan Katz, L. Jay Moster, Marlene R. Milcarek, Barry Abu-Amero, Khaled K. |
author_facet | Bosley, Thomas M. Hellani, Ali Spaeth, George L. Myers, Jonathan Katz, L. Jay Moster, Marlene R. Milcarek, Barry Abu-Amero, Khaled K. |
author_sort | Bosley, Thomas M. |
collection | PubMed |
description | PURPOSE: Heterozygous optic atrophy type1 (OPA1) mutations are responsible for dominant optic atrophy, and the down regulation of OPA1 expression in patients with Leber hereditary optic neuropathy may imply that Opa1 protein levels in mitochondria play a role in other spontaneous optic neuropathies as well. Mitochondrial and metabolic abnormalities may put the optic nerve at risk in primary open angle glaucoma (POAG), and this preliminary study was designed to investigate whether altered OPA1 expression might be present in the progressive optic neuropathy of POAG. METHODS: Patients were eligible for inclusion if they met standard clinical criteria for POAG, including age greater than 40 years, intraocular pressure ≥ 21 mmHg in at least one eye before treatment, normal-appearing anterior chamber angles bilaterally on gonioscopy, and optic nerve injury characteristic of POAG. RNA was extracted from leukocytes and converted to cDNA by reverse transcriptase enzyme, and real time PCR was used to assess expression levels of OPA1 and the β-globulin (HBB) housekeeping gene. The ratio of OPA1 expression to HBB expression (OPA1/HBB) for POAG patients was compared to that of controls and to clinical characteristics of POAG patients. RESULTS: Forty-three POAG patients and 27 controls were completely phenotyped with a full ophthalmologic examination and static perimetry. Mean age (POAG 67.9 years; controls 61.8 years) and sex (POAG 26 males/17 females; controls 11/16) were similar for the two groups. Mean OPA1/HBB of POAG patients (1.16, SD 0.26) was 18% lower than controls (1.41, SD 0.50), and this difference was statistically significant (p≤0.021). OPA1 expression differed between the groups (p≤0.037), but HBB expression did not differ (p≤0.24). OPA1/HBB was not correlated with any clinical feature of POAG patients. CONCLUSIONS: Transcriptional analysis of peripheral blood leucocytes is a limited model system for studying the consequences of mitochondrial abnormalities in the optic nerve. Nevertheless, OPA1 is known to affect mitochondrial stability and has now been implicated in several spontaneous optic neuropathies. Decreased OPA1 expression in POAG patients is another indication that mitochondrial function, and possibly mitochondrially-induced apoptosis, may play a role in the development of POAG. |
format | Text |
id | pubmed-3086630 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Molecular Vision |
record_format | MEDLINE/PubMed |
spelling | pubmed-30866302011-05-06 Down-regulation of OPA1 in patients with primary open angle glaucoma Bosley, Thomas M. Hellani, Ali Spaeth, George L. Myers, Jonathan Katz, L. Jay Moster, Marlene R. Milcarek, Barry Abu-Amero, Khaled K. Mol Vis Research Article PURPOSE: Heterozygous optic atrophy type1 (OPA1) mutations are responsible for dominant optic atrophy, and the down regulation of OPA1 expression in patients with Leber hereditary optic neuropathy may imply that Opa1 protein levels in mitochondria play a role in other spontaneous optic neuropathies as well. Mitochondrial and metabolic abnormalities may put the optic nerve at risk in primary open angle glaucoma (POAG), and this preliminary study was designed to investigate whether altered OPA1 expression might be present in the progressive optic neuropathy of POAG. METHODS: Patients were eligible for inclusion if they met standard clinical criteria for POAG, including age greater than 40 years, intraocular pressure ≥ 21 mmHg in at least one eye before treatment, normal-appearing anterior chamber angles bilaterally on gonioscopy, and optic nerve injury characteristic of POAG. RNA was extracted from leukocytes and converted to cDNA by reverse transcriptase enzyme, and real time PCR was used to assess expression levels of OPA1 and the β-globulin (HBB) housekeeping gene. The ratio of OPA1 expression to HBB expression (OPA1/HBB) for POAG patients was compared to that of controls and to clinical characteristics of POAG patients. RESULTS: Forty-three POAG patients and 27 controls were completely phenotyped with a full ophthalmologic examination and static perimetry. Mean age (POAG 67.9 years; controls 61.8 years) and sex (POAG 26 males/17 females; controls 11/16) were similar for the two groups. Mean OPA1/HBB of POAG patients (1.16, SD 0.26) was 18% lower than controls (1.41, SD 0.50), and this difference was statistically significant (p≤0.021). OPA1 expression differed between the groups (p≤0.037), but HBB expression did not differ (p≤0.24). OPA1/HBB was not correlated with any clinical feature of POAG patients. CONCLUSIONS: Transcriptional analysis of peripheral blood leucocytes is a limited model system for studying the consequences of mitochondrial abnormalities in the optic nerve. Nevertheless, OPA1 is known to affect mitochondrial stability and has now been implicated in several spontaneous optic neuropathies. Decreased OPA1 expression in POAG patients is another indication that mitochondrial function, and possibly mitochondrially-induced apoptosis, may play a role in the development of POAG. Molecular Vision 2011-04-27 /pmc/articles/PMC3086630/ /pubmed/21552501 Text en Copyright © 2011 Molecular Vision. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bosley, Thomas M. Hellani, Ali Spaeth, George L. Myers, Jonathan Katz, L. Jay Moster, Marlene R. Milcarek, Barry Abu-Amero, Khaled K. Down-regulation of OPA1 in patients with primary open angle glaucoma |
title | Down-regulation of OPA1 in patients with primary open angle glaucoma |
title_full | Down-regulation of OPA1 in patients with primary open angle glaucoma |
title_fullStr | Down-regulation of OPA1 in patients with primary open angle glaucoma |
title_full_unstemmed | Down-regulation of OPA1 in patients with primary open angle glaucoma |
title_short | Down-regulation of OPA1 in patients with primary open angle glaucoma |
title_sort | down-regulation of opa1 in patients with primary open angle glaucoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086630/ https://www.ncbi.nlm.nih.gov/pubmed/21552501 |
work_keys_str_mv | AT bosleythomasm downregulationofopa1inpatientswithprimaryopenangleglaucoma AT hellaniali downregulationofopa1inpatientswithprimaryopenangleglaucoma AT spaethgeorgel downregulationofopa1inpatientswithprimaryopenangleglaucoma AT myersjonathan downregulationofopa1inpatientswithprimaryopenangleglaucoma AT katzljay downregulationofopa1inpatientswithprimaryopenangleglaucoma AT mostermarlener downregulationofopa1inpatientswithprimaryopenangleglaucoma AT milcarekbarry downregulationofopa1inpatientswithprimaryopenangleglaucoma AT abuamerokhaledk downregulationofopa1inpatientswithprimaryopenangleglaucoma |